Ignite Creation Date:
2024-06-16 @ 11:51 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06440525
Status:
RECRUITING
Last Update Posted:
2024-06-04
First Post:
2024-05-28
Brief Title:
A Study of RSLV-132 in Females with Primary Sjögren39s Syndrome
Sponsor:
Resolve Therapeutics
Organization:
Resolve Therapeutics
Organization Data
Organization:
Resolve Therapeutics
Class:
INDUSTRY
Study ID:
132-06
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Resolve Therapeutics
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None